Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED - BE0003851681 - REIT

62.95 EUR
-0.15 (-0.24%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Overall AED gets a fundamental rating of 4 out of 10. We evaluated AED against 41 industry peers in the Diversified REITs industry. While AED is still in line with the averages on profitability rating, there are concerns on its financial health. AED is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AED was profitable.
In the past year AED had a positive cash flow from operations.
AED had positive earnings in each of the past 5 years.
In the past 5 years AED always reported a positive cash flow from operatings.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AED has a Return On Assets (2.73%) which is in line with its industry peers.
AED has a Return On Equity (4.96%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.52%, AED is in line with its industry, outperforming 58.54% of the companies in the same industry.
AED had an Average Return On Invested Capital over the past 3 years of 3.33%. This is in line with the industry average of 3.48%.
The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 49.82%, AED is doing good in the industry, outperforming 63.41% of the companies in the same industry.
In the last couple of years the Profit Margin of AED has declined.
AED has a Operating Margin of 77.70%. This is in the better half of the industry: AED outperforms 70.73% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
AED has a Gross Margin of 97.93%. This is amongst the best in the industry. AED outperforms 95.12% of its industry peers.
AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
The number of shares outstanding for AED remains at a similar level compared to 1 year ago.
AED has more shares outstanding than it did 5 years ago.
AED has a worse debt/assets ratio than last year.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that AED is in the distress zone and has some risk of bankruptcy.
AED has a Altman-Z score of 0.78. This is comparable to the rest of the industry: AED outperforms 41.46% of its industry peers.
AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
AED's Debt to FCF ratio of 24.91 is on the low side compared to the rest of the industry. AED is outperformed by 73.17% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, AED is in the better half of the industry, outperforming 75.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.78
ROIC/WACC0.59
WACC5.99%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
AED has a worse Current ratio (0.35) than 60.98% of its industry peers.
AED has a Quick Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
AED has a Quick ratio (0.35) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.71% over the past year.
The Earnings Per Share has been decreasing by -7.20% on average over the past years.
Looking at the last year, AED shows a quite strong growth in Revenue. The Revenue has grown by 8.70% in the last year.
The Revenue has been growing by 23.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)59.71%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-24.33%
Revenue 1Y (TTM)8.7%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%4.94%

3.2 Future

The Earnings Per Share is expected to grow by 3.09% on average over the next years.
The Revenue is expected to grow by 5.03% on average over the next years.
EPS Next Y3.38%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue Next Year6.21%
Revenue Next 2Y5.32%
Revenue Next 3Y5.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.01, which indicates a rather expensive current valuation of AED.
Compared to the rest of the industry, the Price/Earnings ratio of AED is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.06, AED is valued a bit cheaper.
AED is valuated correctly with a Price/Forward Earnings ratio of 12.03.
AED's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, AED is valued a bit cheaper.
Industry RankSector Rank
PE 17.01
Fwd PE 12.03
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AED is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
78.05% of the companies in the same industry are cheaper than AED, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.88
EV/EBITDA 19.91
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.04
PEG (5Y)N/A
EPS Next 2Y3.11%
EPS Next 3Y3.09%

4

5. Dividend

5.1 Amount

AED has a Yearly Dividend Yield of 4.33%, which is a nice return.
Compared to an average industry Dividend Yield of 5.47, AED is paying slightly less dividend.
AED's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.33%

5.2 History

The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
AED's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (9/5/2025, 7:00:00 PM)

62.95

-0.15 (-0.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-28 2025-10-28
Inst Owners40.83%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap2.99B
Analysts76.67
Price Target74.94 (19.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.33%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.86%
PT rev (3m)2.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.98%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 17.01
Fwd PE 12.03
P/S 8.48
P/FCF 28.88
P/OCF 10.25
P/B 0.84
P/tB 0.87
EV/EBITDA 19.91
EPS(TTM)3.7
EY5.88%
EPS(NY)5.23
Fwd EY8.32%
FCF(TTM)2.18
FCFY3.46%
OCF(TTM)6.14
OCFY9.76%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)5.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexcg growth 3Y6.29%
ROICexcg growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.78
F-Score7
WACC5.99%
ROIC/WACC0.59
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.71%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-24.33%
EPS Next Y3.38%
EPS Next 2Y3.11%
EPS Next 3Y3.09%
EPS Next 5YN/A
Revenue 1Y (TTM)8.7%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%4.94%
Revenue Next Year6.21%
Revenue Next 2Y5.32%
Revenue Next 3Y5.03%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year12.16%
EBIT Next 3Y6.92%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%